OpenVSafe by OpenVAERS
Search V-safe

2KE-23773-62597

4 vaccinations 10 coded responses 33 check-ins 10 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
217 / MD
Registered
2021-02-15
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-15
    Registered in v-safe
  2. 2021-02-15
    Dose 1 — Moderna
  3. 2021-02-15
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-02-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · None
    Adult check-in
  5. 2021-02-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-02-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-08
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-12
    Dose 2 — Moderna
  13. 2021-03-12
    Survey response — day 0, dose 2
    MedDRA: Disturbance in attention, Feeling cold, Somnolence — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Grogginess, inability to concentrate, chilly but not chills.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Disturbance in attention — Feeling: Poor · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Difficulty concentrating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-03-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Feeling cold — Feeling: Fair · Site: Redness, Swelling · Headache, Fatigue or tiredness
    Free text: Feeling cold but no chills.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Feeling cold — Feeling: Good · Fatigue or tiredness
    Free text: No chills, but chilly.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  19. 2021-03-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Night sweats — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Night sweats
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-19
    Survey response — day 7, dose 2
    MedDRA: Swelling face — Feeling: Good · Headache, Fatigue or tiredness
    Free text: Puffy face.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-09
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-04-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-23
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-06-14
    Survey response — 3 months, dose 2
    MedDRA: Muscle spasms, Poor peripheral circulation — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Poor blood circulation in legs; muscle spasms in neck.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-09-10
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-11-04
    Dose 3 — Moderna
  29. 2022-03-13
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in
  30. 2022-10-26
    Dose 4 — Moderna
  31. 2022-11-04
    Survey response — day 7, dose 4
    MedDRA: Body temperature decreased — Feeling: Good
    Free text: In general, body temperature feels cooler than normal post 4th dose
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-11-09
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  33. 2022-11-16
    Survey response — day 21, dose 4
    MedDRA: Constipation, Fatigue, Menstruation irregular, Peripheral coldness, Poor peripheral circulation, Swelling face, Therapeutic response unexpected — Feeling: Fair
    Free text: Greater fatigue, period started 3 days early without usual cramping, puffy face, poorer blood circulation in legs, colder extremities, constipation
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-11-23
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  35. 2022-12-02
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-12-07
    Survey response — day 42, dose 4
    MedDRA: Fatigue, Poor peripheral circulation — Feeling: Fair
    Free text: Blood circulation feels poorer, more fatigue.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2023-01-27
    Health check-in — 3 months, dose 4
    Feeling: Fair
    Adult check-in
  38. 2023-04-28
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-15Moderna
22021-03-12Moderna
32021-11-04Moderna No
42022-10-26Moderna No

Free text

Release 5 — day 0, dose 2

2021-03-12

Systemic reaction (other): Grogginess, inability to concentrate, chilly but not chills.

Release 5 — days 1–6 daily, dose 2

2021-03-13

Systemic reaction (other): Difficulty concentrating

2021-03-15

Systemic reaction (other): Feeling cold but no chills.

2021-03-16

Systemic reaction (other): No chills, but chilly.

2021-03-18

Systemic reaction (other): Night sweats

Release 5 — day 7, dose 2

2021-03-19

Systemic reaction (other): Puffy face.

Release 9 — 3 months, dose 2

2021-06-14

Symptoms: Poor blood circulation in legs; muscle spasms in neck.

Release 12 — day 7, dose 4

2022-11-04

Systemic reaction (other): In general, body temperature feels cooler than normal post 4th dose

Release 12 — day 21, dose 4

2022-11-16

Symptoms: Greater fatigue, period started 3 days early without usual cramping, puffy face, poorer blood circulation in legs, colder extremities, constipation

Release 12 — day 42, dose 4

2022-12-07

Symptoms: Blood circulation feels poorer, more fatigue.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDConstipation · · ✓
SDFatigue · · ✓
SDMenstruation irregular · · ✓
SDMuscle spasms ✓ ✓ ✓
SDPeripheral coldness · · ✓
SDPoor peripheral circulation ✓ ✓ ✓
SDSwelling face · · ✓
SDTherapeutic response unexpected · · ✓
SROBody temperature decreased · · ✓
SRODisturbance in attention ✓ ✓ ✓
SROFeeling cold ✓ ✓ ✓
SRONight sweats ✓ ✓ ✓
SROSomnolence ✓ ✓ ✓
SROSwelling face ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release